.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Moodys
UBS
Cipla
AstraZeneca
Mallinckrodt
Merck
McKesson
US Army

Generated: December 13, 2017

DrugPatentWatch Database Preview

Synergy Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for SYNERGY PHARMS, and when can generic versions of SYNERGY PHARMS drugs launch?

SYNERGY PHARMS has one approved drug.

There are five US patents protecting SYNERGY PHARMS drugs.

There are forty-one patent family members on SYNERGY PHARMS drugs in thirteen countries.

Summary for Synergy Pharms

International Patents:41
US Patents:5
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Synergy PharmsTRULANCEplecanatideTABLET;ORAL208745-001Jan 19, 2017RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Synergy PharmsTRULANCEplecanatideTABLET;ORAL208745-001Jan 19, 2017RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Synergy PharmsTRULANCEplecanatideTABLET;ORAL208745-001Jan 19, 2017RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Synergy PharmsTRULANCEplecanatideTABLET;ORAL208745-001Jan 19, 2017RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Synergy PharmsTRULANCEplecanatideTABLET;ORAL208745-001Jan 19, 2017RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Synergy PharmsTRULANCEplecanatideTABLET;ORAL208745-001Jan 19, 2017RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Synergy Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,114,831Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Synergy Pharms Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2013138352► Subscribe
Eurasian Patent Organization201491697► Subscribe
Spain2330312► Subscribe
China103638514► Subscribe
Hong Kong1196135► Subscribe
Canada2905585► Subscribe
Japan4206272► Subscribe
Cyprus1109504► Subscribe
World Intellectual Property Organization (WIPO)02078683► Subscribe
Germany60233040► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Federal Trade Commission
Chinese Patent Office
Julphar
Colorcon
US Department of Justice
QuintilesIMS
Fuji
UBS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot